Main content

Date created: | Last Updated:

: DOI | ARK

Creating DOI. Please wait...

Create DOI

Category: Other

Description: Our research group aims to produce and disseminate knowledge on the role of selected human viruses in the development of human cancers, as well as to contribute for better understanding of the biology of malignant tumors. We conduct studies for a better understanding of the role of carcinogenic viruses, notably the Epstein-Barr virus (EBV) and the Kaposi Sarcoma virus (KSHV), in the etiopathogenesis of cancers in humans, whether in immunocompetent individuals or people living with the human immunodeficiency virus (HIV). Furthermore, we evaluate the possible effects of constitutional factors, viral products, natural products or other compounds on the biological aggressiveness of cancers, particularly by modifying tumor progression phenomena, such as neoplastic invasion and metastatic dissemination. Our studies are mostly based on human lymphomas, carcinomas, and sarcomas as experimental models. We are part of the Sao Paulo State University (UNESP), Botucatu School of Medicine, and our laboratory is located at the Institute for Biotechnology (IBTEC), UNESP, in Botucatu, SP, Brazil. Website: http://virican.net

License: CC-By Attribution 4.0 International

Wiki

Add important information, links, or images here to describe your project.

Files

Loading files...

Citation

Components

Cancer progression modifiers


Recent Activity

Loading logs...

Tags

Recent Activity

Loading logs...

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.